Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: Diastolic blood pressure has been evaluated in different prospective cohort studies and in pharmacological intervention trials, which have shown the increased risk of cardiovascular events in hypertensive patients and the benefits of antihypertensive therapy. Aims: To show that systolic blood pressure is at least as important as, or even more important than, diastolic blood pressure as a risk factor for cardiovascular complications. Methods: Review of medical literature. Results: Large epidemiological trials such as the Multiple Risk Factors Intervention Trial (MRFIT) and the Framingham study have shown that systolic blood pressure is an independent, continuous and modifiable risk for all cardiovascular complications, and in elderly subjects isolated systolic hypertension is the most frequent form of hypertension. In elderly subjects the increased stiffness of large arteries is responsible for the early reflection of pulse wave and for the decrease in diastolic blood pressure due to reduced recoil of large arteries. This is summarized in the increase in pulse pressure, which is directly related to the risk of cardiovascular complications. Three large intervention trials in elderly patients with isolated systolic hypertension have shown the relevant cardiovascular benefit of pharmacological reduction of elevated systolic blood pressure and normal diastolic values: the cardiovascular benefit is similar to that found in the general hypertensive population and in elderly patients with systolic-diastolic hypertension. Conclusion: Systolic blood pressure represents an important risk factor for cardiovascular events which can be prevented or reduced with pharmacological treatment. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish
JournalJournal of Hypertension, Supplement
Volume18
Issue number3
Publication statusPublished - 2000

Fingerprint

Antihypertensive Agents
Blood Pressure
Therapeutics
Hypertension
Pharmacology
Arteries
Pulse
Reference Values
Cohort Studies
Prospective Studies

Keywords

  • Cardiovascular risk
  • Elderly
  • Isolated systolic hypertension
  • Systolic and diastolic blood pressure

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{83ee971eae4246f4afae15da4a1bae7f,
title = "Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?",
abstract = "Background: Diastolic blood pressure has been evaluated in different prospective cohort studies and in pharmacological intervention trials, which have shown the increased risk of cardiovascular events in hypertensive patients and the benefits of antihypertensive therapy. Aims: To show that systolic blood pressure is at least as important as, or even more important than, diastolic blood pressure as a risk factor for cardiovascular complications. Methods: Review of medical literature. Results: Large epidemiological trials such as the Multiple Risk Factors Intervention Trial (MRFIT) and the Framingham study have shown that systolic blood pressure is an independent, continuous and modifiable risk for all cardiovascular complications, and in elderly subjects isolated systolic hypertension is the most frequent form of hypertension. In elderly subjects the increased stiffness of large arteries is responsible for the early reflection of pulse wave and for the decrease in diastolic blood pressure due to reduced recoil of large arteries. This is summarized in the increase in pulse pressure, which is directly related to the risk of cardiovascular complications. Three large intervention trials in elderly patients with isolated systolic hypertension have shown the relevant cardiovascular benefit of pharmacological reduction of elevated systolic blood pressure and normal diastolic values: the cardiovascular benefit is similar to that found in the general hypertensive population and in elderly patients with systolic-diastolic hypertension. Conclusion: Systolic blood pressure represents an important risk factor for cardiovascular events which can be prevented or reduced with pharmacological treatment. (C) 2000 Lippincott Williams and Wilkins.",
keywords = "Cardiovascular risk, Elderly, Isolated systolic hypertension, Systolic and diastolic blood pressure",
author = "G. Leonetti and C. Cuspidi and M. Facchini and M. Stramba-Badiale",
year = "2000",
language = "English",
volume = "18",
journal = "Journal of Hypertension, Supplement",
issn = "0952-1178",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?

AU - Leonetti, G.

AU - Cuspidi, C.

AU - Facchini, M.

AU - Stramba-Badiale, M.

PY - 2000

Y1 - 2000

N2 - Background: Diastolic blood pressure has been evaluated in different prospective cohort studies and in pharmacological intervention trials, which have shown the increased risk of cardiovascular events in hypertensive patients and the benefits of antihypertensive therapy. Aims: To show that systolic blood pressure is at least as important as, or even more important than, diastolic blood pressure as a risk factor for cardiovascular complications. Methods: Review of medical literature. Results: Large epidemiological trials such as the Multiple Risk Factors Intervention Trial (MRFIT) and the Framingham study have shown that systolic blood pressure is an independent, continuous and modifiable risk for all cardiovascular complications, and in elderly subjects isolated systolic hypertension is the most frequent form of hypertension. In elderly subjects the increased stiffness of large arteries is responsible for the early reflection of pulse wave and for the decrease in diastolic blood pressure due to reduced recoil of large arteries. This is summarized in the increase in pulse pressure, which is directly related to the risk of cardiovascular complications. Three large intervention trials in elderly patients with isolated systolic hypertension have shown the relevant cardiovascular benefit of pharmacological reduction of elevated systolic blood pressure and normal diastolic values: the cardiovascular benefit is similar to that found in the general hypertensive population and in elderly patients with systolic-diastolic hypertension. Conclusion: Systolic blood pressure represents an important risk factor for cardiovascular events which can be prevented or reduced with pharmacological treatment. (C) 2000 Lippincott Williams and Wilkins.

AB - Background: Diastolic blood pressure has been evaluated in different prospective cohort studies and in pharmacological intervention trials, which have shown the increased risk of cardiovascular events in hypertensive patients and the benefits of antihypertensive therapy. Aims: To show that systolic blood pressure is at least as important as, or even more important than, diastolic blood pressure as a risk factor for cardiovascular complications. Methods: Review of medical literature. Results: Large epidemiological trials such as the Multiple Risk Factors Intervention Trial (MRFIT) and the Framingham study have shown that systolic blood pressure is an independent, continuous and modifiable risk for all cardiovascular complications, and in elderly subjects isolated systolic hypertension is the most frequent form of hypertension. In elderly subjects the increased stiffness of large arteries is responsible for the early reflection of pulse wave and for the decrease in diastolic blood pressure due to reduced recoil of large arteries. This is summarized in the increase in pulse pressure, which is directly related to the risk of cardiovascular complications. Three large intervention trials in elderly patients with isolated systolic hypertension have shown the relevant cardiovascular benefit of pharmacological reduction of elevated systolic blood pressure and normal diastolic values: the cardiovascular benefit is similar to that found in the general hypertensive population and in elderly patients with systolic-diastolic hypertension. Conclusion: Systolic blood pressure represents an important risk factor for cardiovascular events which can be prevented or reduced with pharmacological treatment. (C) 2000 Lippincott Williams and Wilkins.

KW - Cardiovascular risk

KW - Elderly

KW - Isolated systolic hypertension

KW - Systolic and diastolic blood pressure

UR - http://www.scopus.com/inward/record.url?scp=0033846794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033846794&partnerID=8YFLogxK

M3 - Article

VL - 18

JO - Journal of Hypertension, Supplement

JF - Journal of Hypertension, Supplement

SN - 0952-1178

IS - 3

ER -